Vaginal atrophy is inflammation, dryness, and thinning of the vaginal walls. Natural remedies include using lubricants, exercising, and staying sexually active. Vaginal atrophy is better known as ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

What is apitegromab for SMA? Apitegromab (SRK-015) is an experimental muscle-directed infusion therapy being developed by Scholar Rock as an add-on treatment to improve motor function in people with ...

A rare genetic condition, Spinal Muscular Atrophy (SMA) affects one in 7,000 people in India. It mostly affects children and often leads to infant mortality In a breakthrough for Spinal Muscular ...

In what could be promising news for patients battling spinal muscular atrophy (SMA), the Delhi High Court has refused to allow a suit by Swiss pharma giant Roche seeking to restrain Indian drugmaker ...

The Mayo Clinic and Exact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with abnormal vaginal bleeding. It analyzes vaginal fluid collected on tampons for ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several companies—including Novartis, Scholar Rock and Biogen—progressing novel candidates through ...

Women with polycystic ovary syndrome (PCOS) find it harder to get pregnant, have more frequent miscarriages and have a higher risk of developing endometrial cancer. PCOS is the most common hormona ...

Imagine a future where treating cystic fibrosis is as simple as taking a deep breath. That’s exactly what a team of pediatric physician-scientists at the Eli and Edythe Broad Center of Regenerative ...

"P-Sam is an exciting new ADC targeting B7-H4, which is expressed in approximately 73% of endometrial cancers," Gaillard said at a late-breaking abstract session. A phase III trial of P-Sam versus ...

Adding GLP-1s to progestin therapy appeared to reduce the risk for endometrial cancer among women with benign uterine or endometrial hyperplasia. Further research is needed to better understand ...